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Abstract
Photodynamic therapy (PDT) - the fourth modality - has been successfully used in the management of early and
advanced pathologies of the head and neck. We studied the effect of this modality on a giant solitary neurofibroma
of the neck. A 70-year-old Caucasian female presented with left neck pain and disfigurement associated with slight
shortness of breath and dysphagia. Examination revealed a large mass in the neck with no neurovascular
compromise. Magnetic resonance imaging (MRI) reported a heterogeneously enhancing mass extending from the
left angle of the mandible to the base of the neck. A core biopsy was performed and histopathological examination
revealed a disorganised array of peripheral nerve fascicles. The patient elected to receive photodynamic therapy as
the primary intervention. The multi-disciplinary meeting approved the treatment plan. The photosensitizing agent
was mTHPC (0.15 mg/kg), which was systemically administered 96-hours prior to ultrasound (US)-guided light
delivery to the mass, which was undertaken under general anaesthesia. Recovery was uneventful.Post-PDT follow-up
showed that the patient’s pain, dysphagia and shortness of breath issues had improved. The disfigurement of the
neck caused by the mass was no longer a problem. Three months post-PDT, MRI revealed a significant reduction in
the neurofibroma size. PDT was proven as a successful primary intervention for this pathology. However, higher
evidence-based studies are required before this therapy can be proposed as a replacement to any of the other
conventional therapies.
Introduction
Neurofibroma is a rare benign tumour arising from
nerves that is composed of Schwann cells, perineural
cells and fibroblasts. Neurofibromas may present either
as solitary lesions or as part of a syndrome, i.e. neuro-
fibromatosis or von Recklinghausen's disease of the skin
(NF-1) [1-4].
The aetiology behind solitary neurofibroma is still un-
known. Marocchio et al. [1] considered solitary neuro-
fibroma to be hyperplastic hamartomatous malformations
rather than neoplastic. Anatomically, neck neurofibromas
are relatively rare, with slow painless growth. Neurofibro-
mas are usually treated by excision, especially when they
are symptomatic (i.e. pain causing swallowing or breathing
problems) or disfiguring.
Photodynamic therapy (PDT) has been applied in the
management of superficial and deep pathologies
involving the head and neck [5-11]. PDT has been suc-
cessful in managing superficial diseases such as oral pre-
malignant disorders and early (T1/T2) oral cancer [12-
14]. Successful applications were also reported in the
management of nasopharyngeal carcinoma [15,16],
tongue base carcinoma [17-19], subglottic carcinoma
[20], vascular anomalies [5,10,21-23], sarcomas [5,10,24],
pericarotid disease [25], metastatic disease to the orofa-
cial region [26], mantle lymphoma [27] and Kimura dis-
ease [28]. The advancement in photodynamic
applications suggests that PDT may be more effective
when combined with other modalities, (i.e. photochem-
ical internalization [29-33]. Optical diagnostics (i.e. op-
tical coherence tomography) can be used to guide PDT
therapy and assess outcome especially when it comes to
superficial tissue disease, (i.e. skin cancer) [34].
In this case study, we describe an unusual case of soli-
tary neurofibroma of the neck without the stigmas of
NF-1, which was treated with US-guided interstitial
PDT.
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A 70-year-old Caucasian female presented to the UCLH
Head and Neck Unit, London, with a large left neck
mass. Pain and disfigurement were the major complaints.
The pain itself was described as sharp, radiating to the
right ear and exacerbated by turning the head to the
right. The mass had been increasing in size over the last
year and causing significant disfigurement to the left side
of the neck. Other complaints included slight shortness
of breath, mainly on exertion, and mild dysphagia. The
patient's medical history included congestive heart
failure.
Clinical examination revealed a large mass of the left
neck, which was slightly mobile but fixed to deeper tis-
sue with no ulceration of the overlying skin and no
transillumination. There was no neurovascular com-
promise and examination of the cranial nerves in the
area was unremarkable.
Magnetic resonance imaging (MRI) reported a
12 × 12 × 5 cm heterogeneously enhancing mass in the
left base of neck, extending from the left angle of the
mandible to the base of neck. There was invasion of the
surrounding structures, including the sternocleidomas-
toid muscle. However, there was no invasion of neigh-
bouring vascular structures. A surgical core biopsy was
performed under general anaesthesia. Histopathological
assessment revealed a submucosal nodular proliferation
that consisted of a disorganised array of peripheral nerve
fascicles. Within the fascicles, individual nerve fibres
were splayed apart by an increased endoneural matrix.
Surgical excision was initially offered as it represents
the gold-standard treatment, but the patient requested
an alternative less-invasive therapy. Following the multi-
disciplinary meeting (MDM), the patient was offered US-
guided photodynamic therapy using mTHPC as the
photosensitizing agent.
The patient was sensitized 96-hours prior to light de-
livery by the photosensitive agent mTHPC 0.15 mg/kg.
The agent was administered intravenously and the pa-
tient instructed to remain in a dimly lit room until the
day of the procedure (light delivery).
Intra-operatively, an US scan of the area was per-
formed to assess the centre and periphery of the lesion,
as well as its involvement with any neurovascular struc-
tures or hollow organs. Spinal needles were then fed into
the tumour under US-guidance. Optical fibres were then
inserted through the needles and allowed to protrude by
2-3 mm to deliver maximum light to the abnormal tis-
sue. As the diameter of necrosis post-PDT does not ex-
ceed 1 cm, the needles were pulled back 1 cm at a time
to allow treatment of the whole tumour mass. The total
energy delivered per port was 20 J/cm2 (Figure 1).
Pain, with slight dysphagia and odynophagia were the
main issue in the immediate post-PDT phase. The painwas manageable by simple analgesics and settled com-
pletely within 5–7 days.
Post-PDT follow-up showed that the patient’s pain,
dysphagia and shortness of breath issues had been
improved. The disfigurement of the neck caused by the
mass was no longer evident. Three months post-PDT,
MRI revealed a significant reduction in the neurofibroma
size (Figure 2). The patient is now four years post-inter-
vention and continues to complain of no quality of life
issues.
Discussion
The gold-standard treatment for neurofibromas continues
to be surgery. In the head and neck, this often presents a
challenge because complete excision of these benign
tumours may result in greater morbidity due to the com-
plicated anatomy. In some cases, complete excision may
require sacrifice of the cranial nerves, causing significant
functional and loco-regional deficits, or result in substan-
tial cosmetic deformity. Subtotal resection may allow
reduced morbidity but inevitably leads to recurrence [1-4].
There have been very few alternatives to surgery.
Radiotherapy is often not feasible when dealing with a
diffuse form of the disease. For solitary plexiform neuro-
fibroma of the head and neck, however, radiotherapy
may have a role in shrinking these lesions and control-
ling their growth. Intensity-modulated radiotherapy was
shown to be effective in controlling extensive or recur-
rent juvenile angiofibroma [2].
Our patient had a lesion causing refractory pain, dys-
phagia and some breathing problems, especially on exer-
tion. Although resection has been the treatment of
choice for these lesions, PDT was employed due to the
patient’s choice. PDT led to significant reduction in the
lesion size after only one round of treatment. This has
led to complete symptoms resolution with no morbidity.
Successful treatment of these lesions does not require a
complete PDT response and the possibility remains that
a further round of PDT could be employed, especially in
the case of regrowth and recurrence of symptoms.
We believe that the application of three-dimensional
PDT can be instrumental in eliminating disease and
reduces the chances of recurrence. The aim here was to
ensure that the disease margins are dealt with and noth-
ing gets missed. With regards to neurofibromas, due to
the non-malignant nature of the disease, shrinkage and
control of disease progression and symptoms may be sat-
isfactory to the patient and also avoid exposing the pa-
tient to a major and sometimes disfiguring surgery.
Although the patient continues to be symptom-free after
four years since intervention, continuous surveillance is
recommended due to the small risk of malignant trans-
formation. This has been reported to occur infrequently
with acoustic neuromas treated with radiotherapy [3,4].
Figure 2 Axial MRI scanning of neurofibroma of the neck. A: Baseline MRI showing a large lesion of the left neck compressing the nearby
hollow organs, causing a slight breathing and swallowing compromise. B and C: three months post-PDT scans, slightly upper and lower to the
pre-PDT scan level, showing significant shrinkage with an increase in airway patency.
Figure 1 PDT of neurofibroma. A: Intra-operative image showing the large mass of the left neck. B: Intra-operative ultrasonography assessing the
centre and periphery of the lesion as well as any neurovascular involvement or involvement of hollow organs. C and D: On-table US images showing
the neurofibroma and its boundaries. E: Needle insertion into lesion prior to fibre insertion. F and G: light delivery to initiate the photochemical reaction.
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Solitary plexiform neurofibromas of the head and neck oc-
curring outside the setting of NF-I are rare. Because of the
infiltrative quality of these lesions, complete surgical excision
can be difficult and may result in significant morbidity. PDT
has been used successfully to treat similar benign tumours of
the head and neck. Current state-of-the-art PDT techniques,
which can limit harmful effects to surrounding normal struc-
tures, provide a viable therapeutic option in cases where
complete excision poses an unjustifiably high risk of morbid-
ity. This case study showed that PDT was effective in shrink-
ing the neurofibroma and controlling its progression leading
to symptom control and no morbidity.
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